AIRW - Airware Labs Corp.

Other OTC - Other OTC Delayed Price. Currency in USD

Airware Labs Corp.

7377 East Doubletree Ranch Road
Suite A-260
Scottsdale, AZ 85258
United States
480-463-4246
http://investor.airwarelabs.com

SectorHealthcare
IndustryMedical Appliances & Equipment
Full Time Employees

Key Executives

NameTitlePayExercisedAge
Mr. Jeffrey I. RassasChairman and Chief Exec. Officer200.77kN/A54
Dr. Daniel E. Cohen M.D., Ph.D.Pres, Chief Medical Officer and Director15.62kN/A64
Ms. Jessica L. Smith CPAChief Financial Officer, Chief Accounting Officer, Sec. and Treasurer87.5kN/A38
Mr. Robert J. ZappaDirector of Sales and DistributionN/AN/AN/A
Mr. Chase HerschmanDirector of MarketingN/AN/AN/A
Amounts are as of December 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Airware Labs Corp. develops, manufactures, and distributes nasal breathing devices. The company’s products include Air Allergy, a discreet personal filter, which protects from irritating airborne allergens; and Air Sleep/Snore, a drug-free relief for congestion and snoring caused by nasal breathing difficulties. It focuses on offering its products to sleeping partners, individuals with chronic sinus issues, individuals that suffer from chronic sleep disorders, and individuals with allergies in the United States, Canada, Asia, and the European Union. The company was founded in 2010 and is headquartered in Scottsdale, Arizona.

Corporate Governance

Airware Labs Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.